Brian Freeman/LinkedIn
Aug 21, 2026, 08:32
Brian Freeman: Supporting Innovation in Rare Blood Disorders
Brian Freeman, Sr Manager, Leadership Search and Scouting at Sanofi, shared a post on LinkedIn:
“While a rare blood disorder diagnosis can reshape the path ahead, it doesn’t define what’s possible.
At Sanofi, we’re committed to advancing research and supporting scientific innovation to help create more possibilities for the rare blood disorders community.
This starts with listening to people living with hemophilia and immune thrombocytopenia (ITP) to understand their unique needs, and using those insights to help shape progress for the rare blood disorders community.
Hear patient perspectives, discover resources, and learn more about rare blood disorders.”

Stay updated with Hemostasis Today.
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing
-
Nov 19, 2026, 14:19Long-Read Sequencing Is Closing Diagnostic Gaps in Inherited Bleeding Disorders
-
Nov 19, 2026, 13:36Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
-
Nov 19, 2026, 13:26M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
-
Nov 19, 2026, 13:18Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance
-
Nov 19, 2026, 12:56Batool Abuhalimeh: The Hidden Psychological Burden of Pulmonary Embolism
-
Nov 19, 2026, 12:45Pedro Perez: PE Recovery – From Acute Treatment to Long-Term Follow-Up